Media Inquiries

Cognate’s team is available to discuss our recent news further.

Contact

Join Cognate BioServices at the CAR-TCR Summit in Boston

September 14-17, 2020 Boston, MA Read More

Phacilitate Leaders Europe Forum

September 29th-30th, 2020 London, UK Read More

Meeting on the Mesa

October 14-16, 2020 in Carlsbad, California Read More

Cognate BioServices announces acquisition of Cobra Biologics

Cognate BioServices announces acquisition of Cobra Biologics Transformative acquisition creates global cell and gene therapy manufacturing services platform for both... Read More

Cognate BioServices Secures Growth Capital Investment from EW Healthcare to Continue to Expand Commercial Manufacturing Capacity and Services for the Cellular Therapies Industry

Cognate BioServices Secures Growth Capital Investment from EW Healthcare to Continue to Expand Commercial Manufacturing Capacity and Services for the Cellular Therapies Industry ... Read More

Caladrius Biosciences and Cognate BioServices Establish Manufacturing Agreement for Phase 3 Confirmatory Pivotal Clinical Trial of CLBS14 in No-option Refractory Disabling Angina

Caladrius Biosciences and Cognate BioServices Establish Manufacturing Agreement for Phase 3 Confirmatory Pivotal Clinical Trial of CLBS14 in No-option Refractory Disabling Angina ... Read More

Cognate BioServices, Inc. (Memphis, TN) receives Statement of Compliance to EU Good Manufacturing Practice for manufacture of Advanced Therapeutic Medicinal Products

Memphis, June 10, 2019 – Cognate BioServices, Inc., a leading contract development and manufacturing organization (“CDMO”) in the global cellular therapies industry, today... Read More

Cognate BioServices and Astero Bio Corporation Announce Collaboration for Innovation and Development Center of Excellence in Memphis, TN.

Memphis, TN & Menlo Park, CA.  January 22nd, 2019 – Cognate BioServices, Inc., a leading contract development and manufacturing organization (“CDMO”) in the global cellular... Read More

Cognate BioServices and Terumo BCT Announce Collaboration Agreement for Innovation and Development Center of Excellence In Memphis, TN.

Memphis, TN September 28th, 2018 – Cognate BioServices, a leading contract development and manufacturing organization (“CDMO”) in the global cellular therapies industry, today... Read More

Cognate BioServices and FloDesign Sonics Announce Collaboration to Advance Acoustic Cell Processing as a Platform for Cell Therapy Manufacturing

Cognate BioServices and FloDesign Sonics Announce Collaboration to Advance Acoustic Cell Processing as a Platform for Cell Therapy Manufacturing Wilbraham, MA, September 4, 2018 –... Read More
No More Posts